The DNA methylation reader methyl CpG binding protein 2 (MeCP2) can be recruited to the promoter region to inhibit transcription of peroxisome proliferator-activated receptor γ (PPARγ), thereby promoting the occurrence of liver fibrosis. The gene discussed is MECP2; the disease is Hepatic fibrosis.